Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4738-4745
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4738
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4738
Figure 4 Next generation sequencing.
A and B: Next generation sequencing of the two different histologic components. KRAS exon 2 p.G12D (variant frequency 4.9%) (A) and TP53 exon 5 p.A161T (variant frequency 6.2%) (B) were identified in the adenocarcinoma component, but not in the well-differentiated neuroendocrine tumor component.
- Citation: Zhao X, Bocker Edmonston T, Miick R, Joneja U. Mixed pancreatic ductal adenocarcinoma and well-differentiated neuroendocrine tumor: A case report. World J Gastrointest Oncol 2024; 16(12): 4738-4745
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4738.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4738